{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:08:24Z","timestamp":1765584504897,"version":"3.48.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2021 Tertiary Education Trust Fund (TetFund) National Research Fund","award":["(NRF2021_SETI_HSW_00478)"],"award-info":[{"award-number":["(NRF2021_SETI_HSW_00478)"]}]},{"name":"2021 Tertiary Education Trust Fund (TetFund) National Research Fund","award":["(NRF2021_SETI_HSW_00478)"],"award-info":[{"award-number":["(NRF2021_SETI_HSW_00478)"]}]},{"name":"2021 Tertiary Education Trust Fund (TetFund) National Research Fund","award":["(NRF2021_SETI_HSW_00478)"],"award-info":[{"award-number":["(NRF2021_SETI_HSW_00478)"]}]},{"name":"2021 Tertiary Education Trust Fund (TetFund) National Research Fund","award":["(NRF2021_SETI_HSW_00478)"],"award-info":[{"award-number":["(NRF2021_SETI_HSW_00478)"]}]},{"name":"2021 Tertiary Education Trust Fund (TetFund) National Research Fund","award":["(NRF2021_SETI_HSW_00478)"],"award-info":[{"award-number":["(NRF2021_SETI_HSW_00478)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27386-y","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T17:36:03Z","timestamp":1764869763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In-silico investigations of bioactive compounds from ginger against Lassa fever virus nucleoprotein"],"prefix":"10.1038","volume":"15","author":[{"given":"Antai E.","family":"Eyo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwem Okon","family":"Edet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohnad","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ini Ubi","family":"Bassey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Al-Shouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Mbim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyad","family":"Kurdee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monera","family":"Alrukhayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edema Enogiomwan","family":"Imalele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okafor Ejike","family":"Reuben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Nwaokorie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement","family":"Meseko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"10","key":"27386_CR1","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/v4102031","volume":"4","author":"NE Yun","year":"2012","unstructured":"Yun, N. E. & Walker, D. H. Pathogenesis of Lassa fever. Viruses 4 (10), 2031\u20132048. https:\/\/doi.org\/10.3390\/v4102031 (2012).","journal-title":"Viruses"},{"issue":"5","key":"27386_CR2","doi-asserted-by":"publisher","first-page":"e14797","DOI":"10.7759\/cureus.14797","volume":"13","author":"A Alli","year":"2021","unstructured":"Alli, A., Ortiz, J. F., Fabara, S. P., Patel, A. & Halan, T. Management of Lassa fever: A current update. Cureus 13 (5), e14797. https:\/\/doi.org\/10.7759\/cureus.14797 (2021).","journal-title":"Cureus"},{"key":"27386_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.coviro.2019.08.002","volume":"37","author":"AN Happi","year":"2019","unstructured":"Happi, A. N., Happi, C. T. & Schoepp, R. J. Lassa fever diagnostics: past, present, and future. Curr. Opin. Virol. 37, 132\u2013138 (2019).","journal-title":"Curr. Opin. Virol."},{"key":"27386_CR4","unstructured":"NCDC. An update of Lassa fever outbreak in Nigeria. Accessed at (2024). https:\/\/ncdc.gov.ng\/diseases\/sitreps\/?cat=5&name=An%20update%20of%20Lassa%20fever %20outbreak%20in%20Nigeria."},{"key":"27386_CR5","unstructured":"Centers for Disease Control and Prevention. Lassa fever is estimated to cause 100,000 to 300,000 infections and 5,000 deaths annually in West Africa. CDC Newsroom. (2024)., October 28 Retrieved from https:\/\/www.cdc.gov\/media\/releases\/2024\/s1028-lassa-fever.html"},{"issue":"2","key":"27386_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/v16020266","volume":"16","author":"RA Reyna","year":"2024","unstructured":"Reyna, R. A. et al. The importance of Lassa fever and its disease management in West Africa. Viruses 16 (2), 266. https:\/\/doi.org\/10.3390\/v16020266 (2024).","journal-title":"Viruses"},{"key":"27386_CR7","doi-asserted-by":"crossref","unstructured":"Qi, X., Lan, S., Wang, W., Schelde, L. M., Dong, H., Wallat, G. D., \u2026 Dong, C. (2010).Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature, 468(7325), 779\u2013783.","DOI":"10.1038\/nature09605"},{"issue":"8","key":"27386_CR8","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.vaccine.2024.02.044","volume":"42","author":"L Kabor\u00e9","year":"2024","unstructured":"Kabor\u00e9, L., Pecenka, C. & Hausdorff, W. P. Lassa fever vaccine use cases and demand: perspectives from select West African experts. Vaccine 42 (8), 1873\u20131877 (2024).","journal-title":"Vaccine"},{"key":"27386_CR9","doi-asserted-by":"crossref","unstructured":"Mateo, M., Reynard, S., Journeaux, A., Germain, C., Hortion, J., Carnec, X., Picard,C., Baillet, N., Borges-Cardoso, V., Merabet, O., Vallve, A., Barron, S., Jourjon,O., Lacroix, O., Duthey, A., Dirheimer, M., Jouvion, G., Moreau, P. H., Fellmann,L., Carbonnelle, C., \u2026 Baize, S. (2021). A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains. Science Translational Medicine, 13(597), eabf6348. https:\/\/doi.org\/10.1126\/scitranslmed.abf6348.","DOI":"10.1126\/scitranslmed.abf6348"},{"issue":"6","key":"27386_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/tmi.13876","volume":"28","author":"G Sulis","year":"2023","unstructured":"Sulis, G., Peebles, A. & Basta, N. E. Lassa fever vaccine candidates: A scoping review of vaccine clinical trials. Tropical Med. Int. Health. 28 (6), 420\u2013431. https:\/\/doi.org\/10.1111\/tmi.13876 (2023).","journal-title":"Tropical Med. Int. Health"},{"issue":"3","key":"27386_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.18683\/germs.2021.1280","volume":"11","author":"IO Ayenigbara","year":"2021","unstructured":"Ayenigbara, I. O., Adegboro, J. S., Ayenigbara, G. O., Adeleke, O. R. & Olofintuyi, O. O. The challenges to a successful COVID-19 vaccination programme in Africa. Germs 11 (3), 427\u2013440. https:\/\/doi.org\/10.18683\/germs.2021.1280 (2021).","journal-title":"Germs"},{"key":"27386_CR12","doi-asserted-by":"crossref","unstructured":"Fischer, R. J., Purushotham, J. N., van Doremalen, N., Sebastian, S., Meade-White,K., Cordova, K., \u2026 Munster, V. J. (2021). ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge. npj Vaccines, 6(1), 32.","DOI":"10.1038\/s41541-021-00291-x"},{"key":"27386_CR13","doi-asserted-by":"crossref","unstructured":"Tschismarov, R., Van Damme, P., Germain, C., De Coster, I., Mateo, M., Reynard, S.,\u2026 Baize, S. (2023). Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial. The Lancet, 401(10384), 1267\u20131276.","DOI":"10.1016\/S0140-6736(23)00048-X"},{"key":"27386_CR14","first-page":"e2021080","volume":"5","author":"E Mbonigaba","year":"2021","unstructured":"Mbonigaba, E. et al. Childhood vaccine uptake in africa: threats, challenges, and opportunities. J. Global Health Rep. 5, e2021080 (2021).","journal-title":"J. Global Health Rep."},{"issue":"2","key":"27386_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41579-022-00789-8","volume":"21","author":"RF Garry","year":"2023","unstructured":"Garry, R. F. Lassa fever\u2014the road ahead. Nat. Rev. Microbiol. 21 (2), 87\u201396 (2023).","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"27386_CR16","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1128\/jvi.01948-08","volume":"83","author":"S Baize","year":"2009","unstructured":"Baize, S. et al. Early and strong immune responses are associated with control of viral replication and recovery in Lassa Virus-Infected cynomolgus monkeys. J. Virol. 83 (11), 5890\u20135903. https:\/\/doi.org\/10.1128\/jvi.01948-08 (2009).","journal-title":"J. Virol."},{"issue":"3","key":"27386_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri.2016.138","volume":"17","author":"JB Prescott","year":"2017","unstructured":"Prescott, J. B. et al. Immunobiology of Ebola and Lassa virus infections. Nat. Rev. Immunol. 17 (3), 195\u2013207. https:\/\/doi.org\/10.1038\/nri.2016.138 (2017).","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"27386_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12985-025-02669-y","volume":"22","author":"S Jan","year":"2025","unstructured":"Jan, S., Phadke, K. S., Lam, V. L., Branda, S. S. & Johnson, D. M. Lassa virus protein-protein interactions as mediators of Lassa fever pathogenesis. Virol. J. 22 (1), 52. https:\/\/doi.org\/10.1186\/s12985-025-02669-y (2025).","journal-title":"Virol. J."},{"issue":"10","key":"27386_CR19","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/vaccines10101668","volume":"10","author":"H Murphy","year":"2022","unstructured":"Murphy, H. & Ly, H. Understanding immune responses to Lassa virus infection and to its candidate vaccines. Vaccines 10 (10), 1668. https:\/\/doi.org\/10.3390\/vaccines10101668 (2022).","journal-title":"Vaccines"},{"issue":"1","key":"27386_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jep.2012.10.043","volume":"145","author":"JS Chang","year":"2013","unstructured":"Chang, J. S., Wang, K. C., Yeh, C. F., Shieh, D. E. & Chiang, L. C. Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J. Ethnopharmacol. 145 (1), 146\u2013151. https:\/\/doi.org\/10.1016\/j.jep.2012.10.043 (2013).","journal-title":"J. Ethnopharmacol."},{"key":"27386_CR21","doi-asserted-by":"crossref","unstructured":"Edet, U. O., Mbim, E. N., Ezeani, E., Henshaw, O. U., Ibor, O. R., Bassey, I. U.,\u2026 Nneoyi-Egbe, A. F. (2023). Antimicrobial analysis of honey against Staphylococcus aureus isolates from wound, ADMET properties of its bioactive compounds and in-silico evaluation against dihydropteroate synthase. BMC Complementary Medicine and Therapies, 23(1), 39.","DOI":"10.1186\/s12906-023-03841-z"},{"key":"27386_CR22","doi-asserted-by":"crossref","unstructured":"Edet, U. O., Nwaokorie, F. O., Mbim, E. N., Asanga, E. E., Agbor, Y. O., Okoroiwu,H. U., \u2026 Nkang, A. (2022). Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against Capsular protein(Cap5O). BMC Complementary Medicine and Therapies, 22(1), 192.","DOI":"10.1186\/s12906-022-03672-4"},{"key":"27386_CR23","doi-asserted-by":"crossref","unstructured":"Mboto, C. I., Edet, U. O., Mbim, E. N., Ndifon, W. O., Ebenso, E. E., Egharevba, H.O., \u2026 Udo, S. I. (2023). In-silico evaluation of bioactive compounds from selected medicinal plants from Southern Nigeria against hepatitis C virus genotype 1 RNA-directed RNA polymerase. Scientific African, 22, e01919.","DOI":"10.1016\/j.sciaf.2023.e01919"},{"key":"27386_CR24","doi-asserted-by":"crossref","unstructured":"Nwaokorie, F., Abdalla, M., Edet, U. O., Abdalla, A. M., Okpo, E. A., Shami, A., \u2026Alaribe, S. C. (2024). In-silico assessment of bioactive compounds from chewing stick(Salvadora persica) against N-acetylneuraminate lyase (5ZKA) of Fusobacterium nucleatum involved in salicyclic acid metabolism. Journal of Molecular Structure, 1316, 138733.","DOI":"10.1016\/j.molstruc.2024.138733"},{"issue":"4","key":"27386_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jtcms.2021.10.001","volume":"8","author":"A Jafarzadeh","year":"2021","unstructured":"Jafarzadeh, A., Jafarzadeh, S. & Nemati, M. Therapeutic potential of ginger against COVID-19: is there enough evidence? J. Traditional Chin. Med. Sci. 8 (4), 267\u2013279 (2021).","journal-title":"J. Traditional Chin. Med. Sci."},{"issue":"6","key":"27386_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/foods8060185","volume":"8","author":"QQ Mao","year":"2019","unstructured":"Mao, Q. Q. et al. Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe). Foods 8 (6), 185. https:\/\/doi.org\/10.3390\/foods8060185 (2019).","journal-title":"Foods"},{"key":"27386_CR27","doi-asserted-by":"publisher","first-page":"100043","DOI":"10.1016\/j.focha.2022.100043","volume":"1","author":"N Promdam","year":"2022","unstructured":"Promdam, N. & Panichayupakaranant, P. [6]-Gingerol: a narrative review of its beneficial effect on human health. Food Chem. Adv. 1, 100043 (2022).","journal-title":"Food Chem. Adv."},{"key":"27386_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s13337-020-00584-0","volume":"31","author":"S Kaushik","year":"2020","unstructured":"Kaushik, S. et al. Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus. VirusDis 31, 270\u2013276. https:\/\/doi.org\/10.1007\/s13337-020-00584-0 (2020).","journal-title":"VirusDis"},{"key":"27386_CR29","doi-asserted-by":"publisher","unstructured":"Shaukat, M. N., Nazir, A. & Fallico, B. Ginger Bioactives: A Comprehensive Review of Health Benefits and Potential Food Applications. Antioxidants, 12(11), 2015. (2023). https:\/\/doi.org\/10.3390\/antiox12112015","DOI":"10.3390\/antiox12112015"},{"key":"27386_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.phytochem.2015.07.012","volume":"117","author":"RB Semwal","year":"2015","unstructured":"Semwal, R. B., Semwal, D. K., Combrinck, S. & Viljoen, A. M. Gingerols and shogaols: important nutraceutical principles from ginger. Phytochemistry 117, 554\u2013568. https:\/\/doi.org\/10.1016\/j.phytochem.2015.07.012 (2015).","journal-title":"Phytochemistry"},{"key":"27386_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2009.10.004","author":"S Dugasani","year":"2010","unstructured":"Dugasani, S. et al. and [6]-shogaol. J. Ethnopharmacol. 127 (2), 515\u2013520. https:\/\/doi.org\/10.1016\/j.jep.2009.10.004 (2010). Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]- gingerol, [10]-gingerol."},{"issue":"10","key":"27386_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1517\/17460441.2012.714363","volume":"7","author":"JA Arnott","year":"2012","unstructured":"Arnott, J. A. & Planey, S. L. The influence of lipophilicity in drug discovery and design. Expert Opin. Drug Discov. 7 (10), 863\u2013875 (2012).","journal-title":"Expert Opin. Drug Discov."},{"issue":"2","key":"27386_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/17460441.2016.1272757","volume":"12","author":"H Yao","year":"2017","unstructured":"Yao, H., Liu, J., Xu, S., Zhu, Z. & Xu, J. The structural modification of natural products for novel drug discovery. Expert Opin. Drug Discov. 12 (2), 121\u2013140 (2017).","journal-title":"Expert Opin. Drug Discov."},{"key":"27386_CR34","doi-asserted-by":"publisher","unstructured":"Helen, M. et al. The Protein Data Bank, Nucleic Acids Research, Volume 28, Issue 1, 1 January Pages 235\u2013242, (2000). https:\/\/doi.org\/10.1093\/nar\/28.1.235","DOI":"10.1093\/nar\/28.1.235"},{"key":"27386_CR35","doi-asserted-by":"crossref","unstructured":"Kechi, E. L., Inah, B. E., Godfrey, O. C., Edet, U. O., Antai, E. E., Ikenyirimba,O. J., \u2026 Louis, H. (2023). X-ray crystallography, Molecular structure investigation,Quantum chemical studies, and molecular dynamic of rheosmin as inhibitors of hemorrhagic Lassa Virus. Journal of Molecular Structure, 136048.","DOI":"10.1016\/j.molstruc.2023.136048"},{"issue":"18","key":"27386_CR36","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1093\/bioinformatics\/btt399","volume":"29","author":"W Huang","year":"2013","unstructured":"Huang, W. et al. Allosite: a method for predicting allosteric sites. Bioinformatics 29 (18), 2357\u20132359. https:\/\/doi.org\/10.1093\/bioinformatics\/btt399 (2013).","journal-title":"Bioinformatics"},{"issue":"18","key":"27386_CR37","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1080\/07391102.2022.2140201","volume":"41","author":"B Kubra","year":"2023","unstructured":"Kubra, B. et al. Inhibition of the predicted allosteric site of the SARS-CoV-2 main protease through flavonoids. J. Biomol. Struct. Dynamics. 41 (18), 9103\u20139120 (2023).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"27386_CR38","doi-asserted-by":"crossref","unstructured":"Zielesny, A. Chemistry Software Package ChemOffice Ultra 2005. (2005).","DOI":"10.1021\/ci050273j"},{"key":"27386_CR39","unstructured":"MOE (The Molecular Operating Environment) Version 2005.06, software available from Chemical Computing Group Inc. 1010 Sherbrooke Street West, Suite 910, Montreal, Canada H3A2R7. http:\/\/www.chemcomp.com"},{"issue":"2","key":"27386_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31 (2), 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"27386_CR41","unstructured":"Jejurikar, B. L. & Rohane, S. H. (2021). Drug designing in discovery studio."},{"issue":"1","key":"27386_CR42","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano, W. L. Pymol: an open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 40 (1), 82\u201392 (2002).","journal-title":"CCP4 Newsl. Protein Crystallogr."},{"key":"27386_CR43","unstructured":"Frisch, M. J. et al. (2009). Gaussian 09 Programmer\u2019s Reference. Gaussian, Inc."},{"issue":"5","key":"27386_CR44","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.drudis.2021.12.017","volume":"27","author":"N Ye","year":"2022","unstructured":"Ye, N., Yang, Z. & Liu, Y. Applications of density functional theory in COVID-19 drug modeling. Drug Discovery Today. 27 (5), 1411\u20131419. https:\/\/doi.org\/10.1016\/j.drudis.2021.12.017 (2022).","journal-title":"Drug Discovery Today"},{"issue":"9","key":"27386_CR45","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. PkCSM: predicting small-molecule Pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58 (9), 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"27386_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.71.e116751","volume":"71","author":"RM Alamsyah","year":"2024","unstructured":"Alamsyah, R. M., Satari, M. H., Pintauli, S. & Iskandar, S. Molecular Docking study of ginger (Zingiber officinale) on Immunoglobulin A for smoking cessation. Pharmacia 71, 1\u20136. https:\/\/doi.org\/10.3897\/pharmacia.71.e116751 (2024).","journal-title":"Pharmacia"},{"issue":"3","key":"27386_CR47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/07391102.2012.703061","volume":"31","author":"L Li","year":"2012","unstructured":"Li, L., Li, D., Chen, H. & Han, J. Studies on the binding modes of Lassa nucleoprotein complexed with m7GpppG and dTTP by molecular dynamic simulations and free energy calculations. J. Biomol. Struct. Dynamics. 31 (3), 299\u2013315. https:\/\/doi.org\/10.1080\/07391102.2012.703061 (2012).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"27386_CR48","doi-asserted-by":"crossref","unstructured":"Ameri, A. et al. The efficacy and safety of ginger (Zingiber officinale)rhizome extract in outpatients with COVID-19: A randomized double-blind placebo-control clinical trial. Medicine 103 (22), e38289 (2024).","DOI":"10.1097\/MD.0000000000038289"},{"issue":"5","key":"27386_CR49","doi-asserted-by":"publisher","first-page":"12573","DOI":"10.33263\/BRIAC115.1257312583","volume":"11","author":"B Kikiowo","year":"2021","unstructured":"Kikiowo, B., Oni, E. A., Iwaloye, O. & Kayode, O. Molecular interaction and inhibitory activity of dandelion\u2019s compounds on nucleoprotein: A therapeutic intervention in Lassa fever. Biointerface Res. Appl. Chem. 11 (5), 12573\u201312583 (2021).","journal-title":"Biointerface Res. Appl. Chem."},{"issue":"1","key":"27386_CR50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/2277-9175.166137","volume":"4","author":"SK Verma","year":"2015","unstructured":"Verma, S. K., Yadav, S. & Kumar, A. In Silico prediction of B-and T-cell epitope on Lassa virus proteins for peptide based subunit vaccine design. Adv. Biomedical Res. 4 (1), 201 (2015).","journal-title":"Adv. Biomedical Res."},{"key":"27386_CR51","doi-asserted-by":"publisher","first-page":"1206872","DOI":"10.3389\/fmicb.2023.1206872","volume":"14","author":"S Akash","year":"2023","unstructured":"Akash, S. et al. Development of a new drug candidate for the Inhibition of Lassa virus glycoprotein and nucleoprotein by modification of Evodiamine as promising therapeutic agents. Front. Microbiol. 14, 1206872. https:\/\/doi.org\/10.3389\/fmicb.2023.1206872 (2023).","journal-title":"Front. Microbiol."},{"key":"27386_CR52","doi-asserted-by":"crossref","unstructured":"Antai, E. E., Edet, U. O., Mbim, E. N., Bassey, I. U., Abdelkhalig, S. M., Nwaokorie,F. O., \u2026 Abdalla, M. (2025). In-silico screening of small compounds against Lassa fever haemorrhagic virus nucleoprotein. Scientific Reports, 15(1), 30558.","DOI":"10.1038\/s41598-025-89989-9"},{"issue":"3","key":"27386_CR53","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3390\/ijms23031771","volume":"23","author":"S Rampogu","year":"2022","unstructured":"Rampogu, S., Lee, G., Park, J. S., Lee, K. W. & Kim, M. O. Molecular Docking and molecular dynamics simulations discover Curcumin analogue as a plausible dual inhibitor for SARS-CoV-2. Int. J. Mol. Sci. 23 (3), 1771. https:\/\/doi.org\/10.3390\/ijms23031771 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"27386_CR54","doi-asserted-by":"publisher","first-page":"626363","DOI":"10.3389\/fmolb.2020.626363","volume":"7","author":"C Savojardo","year":"2021","unstructured":"Savojardo, C., Manfredi, M., Martelli, P. L. & Casadio, R. Solvent accessibility of residues undergoing pathogenic variations in humans: from protein structures to protein sequences. Front. Mol. Biosci. 7, 626363 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"27386_CR55","doi-asserted-by":"crossref","unstructured":"Cheng, C. R., Edet, U. O., Benjamin, I., Okoro, C. U., Emori, W., Mbim, E. N., \u2026 Louis,H. (2023). Effect of solvation on the molecular structure, vibrational assignment,nature of bonding, and the antiviral drug-like potential of troxerutin against HBV proteins. Journal of the Indian Chemical Society, 100(6), 100994.","DOI":"10.1016\/j.jics.2023.100994"},{"key":"27386_CR56","doi-asserted-by":"crossref","unstructured":"Eyo, A. E., Obadiah, G. A., Benjamin, I., Edet, U. O., Akor, F. O., Mbim, E., \u2026 Louis,H. (2023). Geometry optimization, impact of solvation on the spectral (FT-IR, UV,NMR) analysis, Quantum chemical parameters, and the bioactivity of feruloyltyramine as a potential anti-Lassa virus agent via molecular docking. Chemical Physics Impact, 7, 100338.","DOI":"10.1016\/j.chphi.2023.100338"},{"key":"27386_CR57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","volume":"101","author":"LZ Benet","year":"2016","unstructured":"Benet, L. Z., Hosey, C. M., Ursu, O. & Oprea, T. I. BDDCS, the rule of 5 and drugability. Adv. Drug Deliv. Rev. 101, 89\u201398. https:\/\/doi.org\/10.1016\/j.addr.2016.05.007 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20133","key":"27386_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46 (1\u20133), 3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"27386_CR59","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.3390\/ijms18122548","volume":"18","author":"M Silva-Abreu","year":"2017","unstructured":"Silva-Abreu, M. et al. Human skin permeation studies with PPAR\u03b3 agonist to improve its permeability and efficacy in inflammatory processes. Int. J. Mol. Sci. 18 (12), 2548. https:\/\/doi.org\/10.3390\/ijms18122548 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"27386_CR60","doi-asserted-by":"publisher","first-page":"708364","DOI":"10.3389\/fchem.2021.708364","volume":"9","author":"N Flores-Holgu\u00edn","year":"2021","unstructured":"Flores-Holgu\u00edn, N., Frau, J. & Glossman-Mitnik, D. In Silico pharmacokinetics, ADMET study and conceptual DFT analysis of two plant cyclopeptides isolated from rosaceae as a computational peptidology approach. Front. Chem. 9, 708364 (2021).","journal-title":"Front. Chem."},{"issue":"1","key":"27386_CR61","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1021\/tx500444e","volume":"28","author":"S Rendic","year":"2015","unstructured":"Rendic, S. & Guengerich, F. P. Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals. Chem. Res. Toxicol. 28 (1), 38\u201342 (2015).","journal-title":"Chem. Res. Toxicol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27386-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:04:13Z","timestamp":1765584253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27386-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27386"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27386-y","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.jep.2009.10.004","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43316"}}